Viewing Study NCT02354261


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-04-15 @ 8:08 PM
Study NCT ID: NCT02354261
Status: COMPLETED
Last Update Posted: 2020-08-05
First Post: 2015-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)
Sponsor: HedgePath Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module